Renhe Pharmaceutical: The company's shareholder dividend return plan for the next three years (2024-2026)
Renhe Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Renhe Pharmaceutical: Announcement on the implementation results of the repurchase of the company's shares and changes in shares
Renhe Pharmaceutical: Announcement on the repurchase ratio of the company's shares reaching 1% and the progress of the repurchase
Renhe Pharmaceutical: Announcement on the progress of share repurchases
Renhe Pharmaceutical: Announcement on the progress of share repurchases
Renhe Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Renhe Pharmaceutical: Company\'s Repurchase Report on the Repurchase of Shares through Centralized Bidding
Renhe Pharmaceutical: The company\'s announcement on a plan to repurchase shares through centralized bidding transactions
Renhe Pharmaceutical: Announcement on the completion of the implementation of the company chairman\'s plan to increase the company\'s share holdings
Renhe Pharmaceutical: Announcement on the increase in the shareholding ratio of the company chairman to 1% and the progress of the plan to increase his holdings
Renhe Pharmaceutical: Announcement on the progress of implementation of the plan to increase the company\'s chairman\'s shareholding
Renhe Pharmaceutical: Announcement on the progress of implementation of the plan to increase the company\'s chairman\'s shareholding
Renhe Pharmaceutical: Announcement on the Company\'s Chairman\'s Plan to Increase the Company\'s Shares
Renhe Pharmaceutical: Announcement on the implementation of the company\'s 2022 equity distribution
Renhe Pharmaceutical: Announcement on 2022 Profit Distribution Plan
Renhe Pharmaceutical: Announcement on 2021 Profit Distribution Plan
Renhe Pharmaceutical: The company's announcement on the completion of the processing of repurchased shares
Renhe Pharmaceutical: Announcement on the implementation results of the repurchase of the company's shares and changes in shares
Renhe Pharmaceutical: Announcement on the repurchase ratio of the company's shares reaching 1%
No Data